KATHARINE CACERES: Open Payments
NPI 1952071730 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 8 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $415 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Janssen Biotech, Inc. | 4 | $95 |
| Daiichi Sankyo Inc. | 1 | $28 |
| PharmaEssentia USA Corporation | 1 | $22 |
| Apellis Pharmaceuticals, Inc. | 1 | $22 |
Products named: TEZSPIRE, TECVAYLI, Enhertu, BESREMI, TALVEY, Empaveli.
Industry payments across NY — which companies pay providers there.
